Where does Pathy Medical, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pathy Medical, LLC ranks #19,010 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pathy Medical, LLC hold?

Pathy Medical, LLC holds 15 US utility patents granted between 2020 and 2024, spanning 7 technology areas.

What is Pathy Medical, LLC's Innovation Score?

Pathy Medical, LLC has an Innovation Score of 46.7 out of 100 (top 20% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pathy Medical, LLC focus on?

Pathy Medical, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents, ranking #1,451 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Pathy Medical, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Pathy Medical, LLC.

What does claim depth mean for Pathy Medical, LLC's patents?

Pathy Medical, LLC's patents average 13.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pathy Medical, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Pathy Medical, LLC

USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pathy ranks #19,010 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.

#19,010
of 49,997 US assignees by volume: Top 20%
by Innovation Score (46.7/100): 13.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R19010 · US Corporation #19,010 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 15 grants
MID-PACK #19,010/49,997
PHOTO-FINISH Parker Hannifin…
CPC-NARROW A61B · 7 areas
INNOV-PAR 46.7/100
CLAIMS-RICH 13.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Parker Hannifin Emea S.à.r.l. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pathy’s 46.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (21%) Velocity 20.0 pts (43%) Breadth 9.4 pts (20%) Claim depth 7.8 pts (17%)

Qualcomm Incorporated · highest

85
Pathy Medical · this assignee

47
3D Lighting… · lowest

7

What this shows Pathy's Innovation Score is 46.7/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Pathy?

Each dot is one of Pathy’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pathy’s own 13.0 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Pathy vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pathy's grants concentrate

Pathy Medical, LLC is a focused PatentsView assignee: 7 CPC subclasses with 80% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2021. By volume, Pathy sits between Parker Hannifin Emea S.à.r.l. and Peterson Manufacturing Company.

Pathy's three-year grant acceleration

Pathy Medical, LLC shows 12 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Parker Hannifin E…

15
Parsons

15
Pathogendx

15
Pathway Innovatio…

15
Peel

15
Performance Drone…

15
Perkinelmer Singa…

15
Peterson Manufact…

15
Pathy Medical ◀

15

What this shows Pathy holds 15 patents at rank #19,025, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pathy

By rank, the assignees closest to #19,025 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Pathy's primary technology class.

Pathy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Pathy Medical, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	13.3%
2021	1	6.7%
2022	4	26.7%
2023	4	26.7%
2024	4	26.7%

Which technologies does Pathy Medical, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

F21Y - Indexing Scheme Associated With Subclasses F21k, F21l, F21s and F21v, Relating TO THE Form OR THE Kind OF THE Light Sources OR OF THE Colour OF THE Light Emitted 8

F21V - Functional Features OR Details OF Lighting Devices OR Systems THEREOF; Structural Combinations OF Lighting Devices With Other Articles, NOT Otherwise Provided FOR 8

F21L - Lighting Devices OR Systems Thereof, Being Portable OR Specially Adapted FOR Transportation 4

F21W - Indexing Scheme Associated With Subclasses F21k, F21l, F21s and F21v, Relating TO Uses OR Applications OF Lighting Devices OR Systems 4

F21S - Non-portable Lighting DEVICES; Systems THEREOF; Vehicle Lighting Devices Specially Adapted FOR Vehicle Exteriors 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Pathy Medical, LLC's patent record in context - here's where to go next.

Pathy Medical, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 80% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #19,010 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pathy Medical, LLC against Parker Hannifin Emea S.à.r.l., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.